Retrospective Study
Copyright ©The Author(s) 2025.
World J Hepatol. May 27, 2025; 17(5): 103852
Published online May 27, 2025. doi: 10.4254/wjh.v17.i5.103852
Figure 1
Figure 1 Recent global prevalence of metabolic dysfunction-associated steatotic liver disease and recent prevalence of metabolic dysfunction-associated steatotic liver disease by continent. Figure 1 was created using ArcMap 10.2. Maps and data were separately sourced from publicly available resources on the websites (Resource and Environmental Science Data Platform, Geoboundaries, etc.) and literature surveys. Figure 1 now incorporates data obtained from recent epidemiological studies on MASLD. MASLD: Metabolic dysfunction-associated steatotic liver disease.